1. A synergistic pharmaceutical combination for the treatment of obesity, overweight and related health problems, characterized in that it contains orlistat or its pharmaceutically acceptable salts, and resveratrol or its pharmaceutically acceptable salts. A pharmaceutical composition, characterized in that it contains a combination according to claim 1 and pharmaceutically acceptable excipients. The pharmaceutical composition according to claim 2, characterized in that it contains from 30 mg to 360 mg of orlistat or its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, characterized in that it contains from 100 mg to 2000 mg of resveratrol or its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, characterized in that it is prepared in the form of an oral composition. The use of the combination of claim 1 for the manufacture of an agent for treating overweight, obesity, and related health problems. The use according to claim 6, wherein the drug contains from 30 mg to 360 orlistat or its pharmaceutically acceptable salts. The use according to claim 6, in which the drug contains from 100 mg to 2000 resveratrol or its pharmaceutically acceptable salts. The use of claim 6, wherein orlistat and resveratrol are present in the same dosage form. The use according to claim 6, wherein orlistat and resveratrol are present in different dosage forms or in different dosage units. The use of the combination according to claim 1 for the treatment of overweight, obesity, and related health problems. A method of preparing a pharmaceutical composition containing orlistat or its1. Синергическая фармацевтическая комбинация для лечения ожирения, избыточной массы тела и связанных с ними проблем со здоровьем, отличающаяся тем, что она содержит орлистат или его фармацевтически приемлемые соли, и ресвератрол или его фармацевтически приемлемые соли.2. Фармацевтическая композиция, отличающаяся тем, что она содержит ком
